What Is the best treatment for HIV-associated multicentric Castleman disease?

Clin Adv Hematol Oncol. 2012 Mar;10(3):207-9.

Authors

Mark Bower¹, Alessia Dalla Pria

Affiliation

¹ Department of Oncology, Chelsea & Westminster Hospital, London, United Kingdom. [email protected]

PMID: 22402432

No abstract available

Publication types

Case Reports
Review

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Castleman Disease / complications
Castleman Disease / diagnosis
Castleman Disease / drug therapy*
HIV Infections / complications
Humans
Rituximab

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab

Supplementary concepts

Multi-centric Castleman's Disease